MARKET

DXCM

DXCM

Dexcom Inc
NASDAQ
89.56
-1.92
-2.10%
Opening 15:46 08/14 EDT
OPEN
91.93
PREV CLOSE
91.48
HIGH
91.93
LOW
89.47
VOLUME
2.56M
TURNOVER
--
52 WEEK HIGH
91.93
52 WEEK LOW
54.11
MARKET CAP
33.80B
P/E (TTM)
35.53
1D
5D
1M
3M
1Y
5Y
1D
1 Surging Stock Worth Your Attention and 2 We Question
Barchart · 17h ago
Citi Reaffirms Their Buy Rating on Dexcom (DXCM)
TipRanks · 1d ago
Is DexCom (DXCM) Fully Valued Following Strong Earnings And Higher Revenue Guidance?
Simply Wall St · 1d ago
Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?
NASDAQ · 2d ago
DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?
NASDAQ · 2d ago
Can DexCom's Raised 2026 Outlook Sustain Stronger Margin Momentum?
NASDAQ · 2d ago
DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?
NASDAQ · 2d ago
Biotech Stocks At 52-Week Highs - ALMR +30% On Q2 Reports, DYN, CGEM, DXCM, CAH
NASDAQ · 2d ago
More
About DXCM
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. It enables people to take control of health through innovative biosensing technology. The G7 is an integrated continuous glucose monitoring system. Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes. The G7 and G7 15 Day includes finger stick elimination, continuous glucose readings and others.

Webull offers DexCom Inc stock information, including NASDAQ: DXCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DXCM stock methods without spending real money on the virtual paper trading platform.